Paxlovid’s Impact on Hospitalization and Death in COVID-Vaccinated Older Adults Far Weaker Than Previously Thought | Newswise

Paxlovid’s Impact on Hospitalization and Death in COVID-Vaccinated Older Adults Far Weaker Than Previously Thought | Newswise

Newswise — Paxlovid does not significantly reduce COVID-19 hospitalization and mortality among vaccinated older adults, according to new UCLA-led research.  The study questions the assumption that Paxlovid’s effectiveness in reducing COVID-19 hospitalizations and deaths in unvaccinated adults also applies to vaccinated adults. Pfizer’s 2022 clinical trial found reduced COVID-19 hospitalization in unvaccinated middle-aged adults; while…

Read More
Standardizing Provider Assessments Reveals Important Information About Gun and Opioid Access for Veterans at Risk of Suicide  | Newswise

Standardizing Provider Assessments Reveals Important Information About Gun and Opioid Access for Veterans at Risk of Suicide | Newswise

Newswise — PHILADELPHIA—Standardizing an assessment process currently used by doctors during care discussions with veterans at risk for suicide in other context could shed more light on the risks related to firearms and opioids.   The findings from researchers at the Perelman School of Medicine at the University of Pennsylvania were reported today in JAMA Network Open. They…

Read More
Why New Precision Oncology Cancer Treatments Benefit Patients of Some Ancestries More Than Others | Newswise

Why New Precision Oncology Cancer Treatments Benefit Patients of Some Ancestries More Than Others | Newswise

BYLINE: Julie Grisham Newswise — Nearly half of all new cancer drugs approved by the U.S. Food and Drug Administration (FDA) over the past quarter-century have received that approval based on their ability to target genetic changes driving tumor growth. Medical oncologists use information about the genetic mutations found in tumors to match patients with…

Read More